Stedim Unifies Businesses Under Stedim Biosystems Name
News Jun 06, 2006
The Stedim Group has announced the unification of all business activities under the marketing name Stedim Biosystems.
This move will bring under one banner the original core business of single-use biotech and I.V. bags with the businesses of Integrated Biosystems (IBI) and Isolateur Dénominateur Commun (IDC) acquired in 2004.
The company logo has also been modified to reflect this change. The name change is designed to facilitate synergy between the businesses.
Further, the Stedim Biosystems name signifies that the group has grown and evolved through the successes of the core businesses and acquisitions.
This change also confirms that the activities of Stedim Biosystems are aligned to meet the challenges of the common mission.
The various activities of Stedim Biosystems will be differentiated in business and marketing communications by the use of identifying phrases: Single-use Systems, Controlled Freeze-Thaw, and Sterile Transfer.
Liliane de Lassus, CEO of Stedim Biosystems, commented, "We are very enthusiastic about uniting all Stedim business activities under the name and logo of Stedim Biosystems."
"This identity is designed to honor the successful history and extensive market recognition of the original Stedim name while pointing to the future of our specific mission in producing complete systems for bioprocessing and drug delivery."
"Only the marketing name, the name by which the company presents the businesses to clients, has been changed."
"The legal names of each business entity, which are only required in legal transactions, will remain unchanged for the foreseeable future."
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal TrialsNews
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019